Med Drug Testing is categorized under Inspection Services in New York City, NY and active since 2011.
Med Drug Testing was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Inspection Services business, which does work in the B2B market, and is classified as a Inspection Services, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Mamadu Barrie, President at the company’s single location by writing to 224 West 35th St # 607, New York City, New York NY 10001 or by phoning (212) 216-9428. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Med Drug Testing |
Contact Person: | Mamadu Barrie, President |
Address: | 224 West 35th St # 607, New York City, New York 10001 |
Phone Number: | (212) 216-9428 |
Website Address: | meddrugtesting.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Inspection Services |
SIC Code: | 7389 |
NAICS Code: | 6214930 |
Share This Business: |
Med Drug Testing was started in 2011 to provide professional Inspection Services under the SIC code 7389 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Mamadu Barrie, President for inquiries that concern Med Drug Testing by calling the company number (212) 216-9428, as your correspondence is most welcome. Additionally, the physical location of the single location of Med Drug Testing can be found at the coordinates 40.751933,-73.990825 as well as the street address 224 West 35th St # 607 in New York City, New York 10001.
For its online presence, you may visit Med Drug Testing’s website at meddrugtesting.com and engage with its social media outlets through on Twitter and on Facebook.